Third Stage of Labor a Swedish Randomized Controlled Trial
NCT ID: NCT01221051
Last Updated: 2025-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1800 participants
INTERVENTIONAL
2006-11-30
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis 1. To detect a 5% difference (15% vs 10%) in blood loss \>1000 mL between the two groups with 80% power (α=0.05), at least 726 subjects were required in each group.
Hypothesis 2. Afterpains are more pronounced in active compared to expectant management during the third stage of labour
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Active Versus Expectant Management of the Third Stage of Labor
NCT00473707
Labor Analgesia in the Latent Phrase
NCT00647725
Spinal Analgesia as Fast Track Painless Labor
NCT05271760
Cervical Traction vs. Active Management of 3rd Stage of Labor
NCT04747015
Active Management of the Third Stage of Labour: Uterine Tonus Assessment by Midwife vs. Patient Self-administration
NCT02223806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Women in labour were asked to participate voluntarily when entering the hospital and after acceptance they were randomised to either active or expectant management of the third stage of labour(EMTSL).
AMTSL included:
* Early cord clamping
* 10 UI oxytocin i.v
* controlled cord traction
* uterine massage after placenta expulsion
EMTSL included:
* early cord clamping
* 2 mL saline solution i.v
* wait for signs of placenta detachment
* encourage the women to push out placenta by her own effort
* uterine massage after placenta expulsion
All blood was measured by weighing bed pads and sanitary towels up to two hours postpartum Assessment of afterpains was performed by a Visual Analogue Scale (VAS) and the Pain-o-meter (POM-WDS) two hours after the delivery of placenta, and the day after childbirth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oxytocin
early cord clamping, administration of oxytocin 10 IU i.v, controlled cord traction, uterine massage after placenta expulsion
active management of the third stage of labor
early cord clamping, administration of oxytocin 10 IU, controlled cord traction, uterine massage after placenta expulsion
saline solution
early cord clamping, wait for signs of placenta detachment, encourage the woman to push out placenta by her own effort, uterine massage after placenta expulsion
expectant management of the third stage of labor
early cord clamping, administer saline solution 2 mL i.v,wait for signs of placenta detachment, encourage the woman to push ot placenta by her own effort, uterine massage after placenta expulsion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
active management of the third stage of labor
early cord clamping, administration of oxytocin 10 IU, controlled cord traction, uterine massage after placenta expulsion
expectant management of the third stage of labor
early cord clamping, administer saline solution 2 mL i.v,wait for signs of placenta detachment, encourage the woman to push ot placenta by her own effort, uterine massage after placenta expulsion
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* gestational age of 34+0 - 43+0 weeks
* singleton, cephalic presentation
* expected vaginal birth
Exclusion Criteria
* previous PPH \>1000 mL
* elective Caesarean section
* pre-eclampsia
* grand multiparity (≥5)
* intrauterine fetal death
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Göteborg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
elisabeth jangsten
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska academy, University of Gothenburg
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VGFOUGSB-8290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.